|
|
| (43 intermediate revisions not shown) |
| Line 16: |
Line 16: |
| | div.text { | | div.text { |
| | padding-right: 20px; | | padding-right: 20px; |
| - | padding-left: 50px; | + | padding-left: 20px; |
| | padding-top:20px; | | padding-top:20px; |
| | padding-bottom:10px; | | padding-bottom:10px; |
| Line 48: |
Line 48: |
| | | | |
| | <div class="text"> | | <div class="text"> |
| | + | |
| | <font color=" #990000" face="arial" size="6"> | | <font color=" #990000" face="arial" size="6"> |
| | <br><br> | | <br><br> |
| Line 55: |
Line 56: |
| | | | |
| | | | |
| - | </div>
| |
| | | | |
| - | <table cellpadding=5px> | + | |
| | + | <table cellpadding=10px> |
| | <th> | | <th> |
| | <td width="500px" height="100%" valign="top" valign="center" > | | <td width="500px" height="100%" valign="top" valign="center" > |
| Line 64: |
Line 65: |
| | | | |
| | <div id="menu"> | | <div id="menu"> |
| - | <a href="https://2011.igem.org/Team:DTU-Denmark-2/results/Proofofconcept/mammalian#Why mammalian cells?" class="h2"> Why mammalian cells?</a><br><br> | + | <a href="https://2011.igem.org/Team:DTU-Denmark-2/results/Proofofconcept/mammalian#Proof of concept" class="h1"> Proof of concept</a><br><br> |
| - | <a href="https://2011.igem.org/Team:DTU-Denmark-2/results/Proofofconcept/mammalian#pJEJAM1" class="h2"> pJEJAM1</a><br><br> | + | <a href="https://2011.igem.org/Team:DTU-Denmark-2/results/Proofofconcept/mammalian#Device BBa_K678049" class="h2"> pJEJAM1 <br> |
| - | <a href="https://2011.igem.org/Team:DTU-Denmark-2/results/Proofofconcept/mammalian#pJEJAM2" class="h2"> pJEJAM2</a><br><br> | + | BBa_K678049</a><br><br> |
| - | <a href="https://2011.igem.org/Team:DTU-Denmark-2/results/Proofofconcept/mammalian#pJEJAM3" class="h2"> pJEJAM3</a><br><br> | + | <a href="https://2011.igem.org/Team:DTU-Denmark-2/results/Proofofconcept/mammalian#Device BBa_K678050" class="h2"> pJEJAM2 <br> |
| - | <a href="https://2011.igem.org/Team:DTU-Denmark-2/results/Proofofconcept/mammalian#pJEJAM4" class="h2"> pJEJAM4</a><br><br> | + | BBa_K678050</a><br><br> |
| - | <a href="https://2011.igem.org/Team:DTU-Denmark-2/results/Proofofconcept/mammalian#pJEJAM5" class="h2"> pJEJAM5</a><br><br> | + | <a href="https://2011.igem.org/Team:DTU-Denmark-2/results/Proofofconcept/mammalian#Device BBa_K678051" class="h2"> pJEJAM3 <br> |
| - | <a href="https://2011.igem.org/Team:DTU-Denmark-2/results/Proofofconcept/mammalian#Play'n'Mix" class="h2"> Play'n'Mix</a><br><br> | + | BBa_K678051</a><br><br> |
| - | <a href="https://2011.igem.org/Team:DTU-Denmark-2/results/Proofofconcept/mammalian#References" class="h2"> References</a><br><br>
| + | <a href="https://2011.igem.org/Team:DTU-Denmark-2/results/Proofofconcept/mammalian#Device BBa_K678052" class="h2"> pJEJAM4 <br> |
| | + | BBa_K678052</a><br><br> |
| | + | <a href="https://2011.igem.org/Team:DTU-Denmark-2/results/Proofofconcept/mammalian#Device BBa_K678053" class="h2"> pJEJAM5 <br> |
| | + | BBa_K678053</a><br><br> |
| | + | <a href="https://2011.igem.org/Team:DTU-Denmark-2/results/Proofofconcept/mammalian#Play'n'Mix" class="h2"> Mix'n'Play</a><br><br> |
| | | | |
| | </div> | | </div> |
| Line 84: |
Line 89: |
| | <br> | | <br> |
| | | | |
| - | <a name="Why mammalian cells?"></a><h2><b>Why mammalian cells?</b></h2> | + | <a name="Proof of concept"></a><h1><b>Proof of concept</b></h1> |
| | <p align="justify"> | | <p align="justify"> |
| - | The potential in biopharmaceuticals produced by mammalian cells is huge (1). Last year the global biopharmaceutical market in 2015 was expected to increase to US$ 167 billion (2). Biopharmaceuticals target diseases such as psoriasis and cancer and are more convenient, safe and effective than the other treatment solutions on the market (3). Compared to microbes mammalian cells have lower yields, are more difficult to handle in the laboratory, are costly and have a slow doubling time. So why use mammalian cells, when microbes such as yeast and E. coli are already used as fast, efficient, and cheap cell factories? <br>
| |
| - | The main and most important answer to this is post-translational modifications (PTMs) (4). The reasons for the importance of the PTMs are the protein stability, ligand binding, and potential result in increased immunogenicity when used for humans (4). Most of the therapeutic proteins approved and currently in development are post-translationally modified, which is not surprising since approximately 50% of human proteins are glycosylated (5,5). <br><br>
| |
| | | | |
| - | With this kept in mind there are some key issues in manufacturing where speed in development plays a prominent role; cell line creation has to be completed as rapidly as possible. To reduce the timelines for cell line creation the Plug’n’Play with DNA assembly standard could be a valuable tool.<br><br>
| + | Five different plasmids were assembled with the Plug ‘n’ Play standard in order to verify that the system functions in mammalian cells. To demonstrate how fast any vector of choice for the expression in mammalian cells can be assembled, we designed a reporter system as proof of concept. <br><br> |
| | + | The plasmids for proof of concept in mammalian cells were constructed with the strong constitutive <a href="http://partsregistry.org/wiki/index.php?title=Part:BBa_J52034">cytomegalovirus (CMV) promotor</a>, the <a href="http://partsregistry.org/wiki/index.php?title=Part:BBa_K678019">BGH terminator</a>, the <a href="http://partsregistry.org/wiki/index.php?title=Part:BBa_K678021">hygromycin marker cassette</a>, and the plasmid backbone <a href="http://partsregistry.org/Part:BBa_K678023">pMam</a>. |
| | + | Different genes encoding fluorescent proteins were used as the gene of interest, and the reporter system can easily be modified to be used for gene expression analysis. All transient transfections were performed in the human derived cell line U-2 OS, kindly provided by the Danish Cancer Society. For microscopy the transfected U-2 OS cells were fixed using 4% formaldehyde, and VECTASHIELD was added to prevent rapid loss of fluorescence while examining the cells with the confocal microscope.<br><br> |
| | + | We have proved that the Plug ‘n’ Play assembly standard can easily be applied for construction of mammalian expression vectors. Transfections and expression of the fluorescent proteins GFP, mCherry, YFP, and CFP were successfully conducted in U-2 OS cells. Furthermore, expression of GFP targeted to the peroxisomes of U-2 OS cells succeeded. Lastly it was shown that mammalian cells can be transfected with different fluorescent proteins simultaneously. <br><br> |
| | | | |
| - | It is not only in the industry a more efficient high throughput cloning system could be valuable, when it comes to constructing DNA libraries from extremely complex DNA populations such as total human genomic DNA the application of the Plug'n'Play standard could reduce the construction time with several weeks.<br><br>
| + | This reporter system could be further developed enabling the localization of proteins to specific organelles. Such a system would allow the study of organelles and other compartments in real time. |
| - | | + | |
| - | To demonstrate how fast any vector of choice for the expression in mammalian cells can be assembled we chose to design a reporter system as proof of concept. This system comprises a backbone plasmid that allows for the amplification in and selection of <i>E. coli</i>, the strong constitutive cytomegalovirus (CMV) promoter, a gene module consisting of a gene encoding a fluorescent protein or a gene encoding a fluorescent protein and a localization signal, the BGH terminator and the hygromycin marker cassette. This reporter system can easily be modified and used for gene expression studies. Furthermore we designed a vector for localization of GFP to the peroxisomes, which for instance could be used to monitor movement and metabolism. The idea is to develop this reporter system so that proteins can be localized to organelles and other subcellular compartments allowing for the study of organelles in real time. We lastly showed that cells can be transfected with different fluorescent proteins which with a further development of the system would allow labeling with different fluorescent proteins.
| + | |
| | | | |
| | </p> | | </p> |
| | | | |
| | | | |
| - |
| |
| - | <br>
| |
| - | <br>
| |
| | <div class="image"> | | <div class="image"> |
| | <br> | | <br> |
| | <br> | | <br> |
| - | <a name="pJEJAM1"></a><h2>pJEJAM1</h2> | + | <a name="Device BBa_K678049"></a><h2>pJEJAM1 BBa_K678049</h2> |
| - | pJEJAM1 is a plasmid intended for transient transfection of mammalian cells. The expression of the green fluorescent protein is under the control of the strong constitutive CMV promoter, which can be seen in the figure below. | + | <a href="http://partsregistry.org/wiki/index.php?title=Part:BBa_K678049">pJEJAM1</a> is a plasmid intended for transient transfection of mammalian cells. The expression of the green fluorescent protein (GFP) is under the control of the strong constitutive CMV promoter, which can be seen in the figure below. |
| | <br> | | <br> |
| | <br> | | <br> |
| Line 111: |
Line 112: |
| | <img src="https://static.igem.org/mediawiki/2011/4/42/Device13.png" height="110px" align="center"> </img> | | <img src="https://static.igem.org/mediawiki/2011/4/42/Device13.png" height="110px" align="center"> </img> |
| | | | |
| - | <br>
| |
| | <br> | | <br> |
| | | | |
| Line 118: |
Line 118: |
| | | | |
| | <tr> | | <tr> |
| - | <td><img src="https://static.igem.org/mediawiki/2011/1/1b/IGEM_001.tif" height="250px" align="center"> </img></td> | + | <td><img src="https://static.igem.org/mediawiki/2011/5/53/IGEM_001.png" height="250px" align="center"> </img></td> |
| - | <td><img src="https://static.igem.org/mediawiki/2011/f/f6/IGEM3.tif" height="250px" align="center"> </img></td> | + | <td><img src="https://static.igem.org/mediawiki/2011/4/4a/IGEM3.png" height="250px" align="center"> </img></td> |
| | </tr> | | </tr> |
| | <tr> | | <tr> |
| - | <td>U-2 OS cells transiently transfected with plasmid pJEJAM1 expressing GFP. This vector provides a good expression and homogenous distribution of GFP. Cells were fixed using 4% formaldehyde and addition of VECTASHIELD. Imaging was performed with a confocal microscope, the white bar has a length of 20μm objective. </td> | + | <td>U-2 OS cells transiently transfected with <a href="http://partsregistry.org/wiki/index.php?title=Part:BBa_K678049">pJEJAM1</a> expressing GFP. This plasmid provides a good expression and homogenous distribution of GFP. The white bar has a length of 20μm. </td> |
| - | <td>U-2 OS cells transiently transfected with pJEJAM1 expressing GFP. This vector provides a good expression and homogenous distribution of GFP. Cells were fixed using 4% formaldehyde and addition of VECTASHIELD. Imaging was performed with a confocal microscope, the white bar has a length of 20μm objective. </td> | + | <td>U-2 OS cells transiently transfected with <a href="http://partsregistry.org/wiki/index.php?title=Part:BBa_K678049">pJEJAM1</a> expressing GFP. This plasmid provides a good expression and homogenous distribution of GFP. The white bar has a length of 20μm. </td> |
| | </tr> | | </tr> |
| | </table> | | </table> |
| | | | |
| | | | |
| - | | + | <br><br> |
| - | | + | <a name="Device BBa_K678050"></a><h2>pJEJAM2 BBa_K678050</h2> |
| - | | + | <a href="http://partsregistry.org/wiki/index.php?title=Part:BBa_K678050">pJEJAM2</a> is a plasmid intended for transient transfection of mammalian cells. The expression of GFP is under the control of the strong constitutive CMV promoter (see the figure below). The peroxisomal targeting signal PTS1 is directly fused to the C-terminal of GFP, this sequence should ensure the localization of GFP to the peroxisomes of the cell. Although the microscopy shows GFP distributed in points, further analysis are necessary to confirm that GFP is in fact is targeted to the peroxisomes. |
| - | <br> | + | |
| - | <br>
| + | |
| - | <br>
| + | |
| - | <br> | + | |
| - | <a name="pJEJAM2"></a><h2>pJEJAM2</h2> | + | |
| - | pJEJAM2 is a plasmid intended for transient transfection of mammalian cells. The expression of the green fluorescent protein (GFP) is under the control of the strong constitutive CMV promoter (see the figure below. The peroxisomal targeting signal PTS1 is directly fused to the C-terminal of GFP, this sequence ensures the localization of GFP to the peroxisomes of the cell. | + | |
| | <br> | | <br> |
| | <br> | | <br> |
| Line 142: |
Line 136: |
| | <img src="https://static.igem.org/mediawiki/2011/3/3c/Devices_12.1.png" height="110px" align="center"> </img> | | <img src="https://static.igem.org/mediawiki/2011/3/3c/Devices_12.1.png" height="110px" align="center"> </img> |
| | | | |
| - | <br>
| |
| | <br> | | <br> |
| | | | |
| Line 149: |
Line 142: |
| | | | |
| | <tr> | | <tr> |
| - | <td><center><img src="https://static.igem.org/mediawiki/2011/c/c5/26.08.2011_12-1%2B16_033.tif" height="250px" align="center"> </img></center></td> | + | <td><center><img src="https://static.igem.org/mediawiki/2011/b/b1/12-1%2B16_034.png" height="250px" align="center"> </img></center></td> |
| | </tr> | | </tr> |
| | <tr> | | <tr> |
| - | <td>U-2 OS cells transiently transfected with plasmid pJEJAM2 expressing GFP localized to the peroxisomes. As can be seen on the picture this vector as intended localizes GFP to the peroxisomes of the cells. Cells were fixed using 4% formaldehyde and addition of VECTASHIELD. Imaging was performed with a confocal microscope, the white bar has a length of 30μm objective. </td> | + | <td>U-2 OS cells transiently transfected with <a href="http://partsregistry.org/wiki/index.php?title=Part:BBa_K678050">pJEJAM2</a> expressing GFP localized to the peroxisomes. As can be seen on the picture this vector most likely localizes GFP to the peroxisomes of the cells. The white bar has a length of 30μm. </td> |
| | </tr> | | </tr> |
| | </table> | | </table> |
| | | | |
| - | | + | <br><br> |
| - | <br> | + | <a name="Device BBa_K678051"></a><h2>pJEJAM3 BBa_K678051</h2> |
| - | <br>
| + | <a href="http://partsregistry.org/wiki/index.php?title=Part:BBa_K678051">pJEJAM3</a> is a plasmid intended for transient transfection of mammalian cells. The expression of the yellow fluorescent protein (YFP), is under the control of the strong constitutive CMV promoter (see the figure below). |
| - | <br>
| + | |
| - | <br> | + | |
| - | <a name="pJEJAM3"></a><h2>pJEJAM3</h2> | + | |
| - | pJEJAM3 is a plasmid intended for transient transfection of mammalian cells. The expression of the yellow fluorescent protein (YFP), is under the control of the strong constitutive CMV promoter (see the figure below). | + | |
| | <br> | | <br> |
| | <br> | | <br> |
| Line 168: |
Line 157: |
| | <img src="https://static.igem.org/mediawiki/2011/f/f6/Device14.png" height="110px" align="center"> </img> | | <img src="https://static.igem.org/mediawiki/2011/f/f6/Device14.png" height="110px" align="center"> </img> |
| | | | |
| - |
| |
| - | <br>
| |
| | <br> | | <br> |
| | | | |
| Line 176: |
Line 163: |
| | | | |
| | <tr> | | <tr> |
| - | <td><img src="https://static.igem.org/mediawiki/2011/9/99/26.08.2011_14%2B16_gul.tif" height="250px" align="center"> </img></td> | + | <td><img src="https://static.igem.org/mediawiki/2011/d/d3/14%2B16_gul.png" height="250px" align="center"> </img></td> |
| - | <td><img src="https://static.igem.org/mediawiki/2011/d/d9/26.08.2011_14_gul.tif" height="250px" align="center"> </img></td> | + | <td><img src="https://static.igem.org/mediawiki/2011/e/e3/1_14_gul.png" height="250px" align="center"> </img></td> |
| | </tr> | | </tr> |
| | <tr> | | <tr> |
| - | <td>U-2 OS cells transiently transfected with plasmid pJEJAM3 expressing YFP. This vector provides a good expression and homogenous distribution of YFP. Cells were fixed using 4% formaldehyde and addition of VECTASHIELD. Imaging was performed with a confocal microscope, the white bar has a length of 40μm objective. </td> | + | <td>U-2 OS cells transiently transfected with <a href="http://partsregistry.org/wiki/index.php?title=Part:BBa_K678051">pJEJAM4</a> expressing YFP. This vector provides a good expression and homogenous distribution of YFP. The white bar has a length of 40μm. </td> |
| - | <td>U-2 OS cells transiently transfected with plasmid pJEJAM3 expressing YFP. This vector provides a good expression and homogenous distribution of YFP. Cells were fixed using 4% formaldehyde and addition of VECTASHIELD. Imaging was performed with a confocal microscope, the white bar has a length of 30μm objective. </td> | + | <td>U-2 OS cells transiently transfected with <a href="http://partsregistry.org/wiki/index.php?title=Part:BBa_K678051">pJEJAM4</a> expressing YFP. This vector provides a good expression and homogenous distribution of YFP. The white bar has a length of 30μm. </td> |
| | </tr> | | </tr> |
| | </table> | | </table> |
| | | | |
| - | | + | <br><br> |
| - | <br> | + | <a name="Device BBa_K678052"></a><h2>pJEJAM4 BBa_K678052</h2> |
| - | <br>
| + | <a href="http://partsregistry.org/wiki/index.php?title=Part:BBa_K678052">pJEJAM4</a> is a plasmid intended for transient transfection of mammalian cells. The expression of mCherry, a red fluorescent protein, is under the control of the strong constitutive CMV promoter (see the figure below). |
| - | <br>
| + | |
| - | <br> | + | |
| - | <a name="pJEJAM4"></a><h2>pJEJAM4</h2> | + | |
| - | pJEJAM4 is a plasmid intended for transient transfection of mammalian cells. The expression of mCherry, a red fluorescent protein, is under the control of the strong constitutive CMV promoter (see the figure below). | + | |
| | <br> | | <br> |
| | <br> | | <br> |
| Line 205: |
Line 188: |
| | | | |
| | <tr> | | <tr> |
| - | <td><img src="https://static.igem.org/mediawiki/2011/1/16/26.08.2011_15_rød-2.tif" height="250px" align="center"> </img></td> | + | <td><img src="https://static.igem.org/mediawiki/2011/c/cf/5_rød-2.png" height="250px" align="center"> </img></td> |
| - | <td><img src="https://static.igem.org/mediawiki/2011/7/72/26.08.2011_15_rød.tif" height="250px" align="center"> </img></td> | + | <td><img src="https://static.igem.org/mediawiki/2011/1/16/26.08.png" height="250px" align="center"> </img></td> |
| | </tr> | | </tr> |
| | <tr> | | <tr> |
| - | <td>U-2 OS cells transiently transfected with plasmid pJEJAM4 expressing mCherry. This vector provides a good expression and homogenous distribution of mCherry. Cells were fixed using 4% formaldehyde and addition of VECTASHIELD. Imaging was performed with a confocal microscope, the white bar has a length of 70μm objective. </td> | + | <td>U-2 OS cells transiently transfected with <a href="http://partsregistry.org/wiki/index.php?title=Part:BBa_K678052">pJEJAM4</a> expressing mCherry. This vector provides a good expression and homogenous distribution of mCherry. The white bar has a length of 70μm. </td> |
| - | <td>U-2 OS cells transiently transfected with plasmid pJEJAM4 expressing mCherry. This vector provides a good expression and homogenous distribution of mCherry. Cells were fixed using 4% formaldehyde and addition of VECTASHIELD. Imaging was performed with a confocal microscope, the white bar has a length of 50μm objective. </td> | + | <td>U-2 OS cells transiently transfected with <a href="http://partsregistry.org/wiki/index.php?title=Part:BBa_K678052">pJEJAM4</a> expressing mCherry. This vector provides a good expression and homogenous distribution of mCherry. The white bar has a length of 50μm. </td> |
| | </tr> | | </tr> |
| | </table> | | </table> |
| | | | |
| | | | |
| - | <br> | + | <br><br> |
| - | <br>
| + | <a name="Device BBa_K678053"></a><h2>pJEJAM5 BBa_K678053</h2> |
| - | <br>
| + | <a href="http://partsregistry.org/wiki/index.php?title=Part:BBa_K678053">pJEJAM5</a> is a plasmid intended for transient transfection of mammalian cells. The expression of cyan fluorescent protein (CFP), is under the control of the strong constitutive CMV promoter (see the figure below). |
| - | <br> | + | |
| - | <a name="pJEJAM5"></a><h2>pJEJAM5</h2> | + | |
| - | pJEJAM5 is a plasmid intended for transient transfection of mammalian cells. The expression of cyan fluorescent protein (CFP), is under the control of the strong constitutive CMV promoter (see the figure below). | + | |
| | <br> | | <br> |
| | <br> | | <br> |
| Line 226: |
Line 206: |
| | <img src="https://static.igem.org/mediawiki/2011/4/4c/Device_16.png" height="110px" align="center"> </img> | | <img src="https://static.igem.org/mediawiki/2011/4/4c/Device_16.png" height="110px" align="center"> </img> |
| | | | |
| - |
| |
| - | <br>
| |
| | <br> | | <br> |
| | | | |
| Line 234: |
Line 212: |
| | | | |
| | <tr> | | <tr> |
| - | <td><img src="https://static.igem.org/mediawiki/2011/0/05/26.08.2011_16_blå-2.tif" height="250px" align="center"> </img></td> | + | <td><img src="https://static.igem.org/mediawiki/2011/0/0d/16_033.png" height="250px" align="center"> </img></td> |
| - | <td><img src="https://static.igem.org/mediawiki/2011/b/bf/26.08.2011_16_blå.tif" height="250px" align="center"> </img></td> | + | <td><img src="https://static.igem.org/mediawiki/2011/9/9e/16_blå.png" height="250px" align="center"> </img></td> |
| | </tr> | | </tr> |
| | <tr> | | <tr> |
| - | <td>U-2 OS cells transiently transfected with plasmid pJEJAM5 expressing CFP. This vector provides a good expression and homogenous distribution of CFP. Cells were fixed using 4% formaldehyde and addition of VECTASHIELD. Imaging was performed with a confocal microscope, the white bar has a length of 70μm objective. </td> | + | <td>U-2 OS cells transiently transfected with <a href="http://partsregistry.org/wiki/index.php?title=Part:BBa_K678053">pJEJAM5</a> expressing CFP. This vector provides a good expression and homogenous distribution of CFP. The white bar has a length of 70μm. </td> |
| - | <td>U-2 OS cells transiently transfected with plasmid pJEJAM5 expressing CFP. This vector provides a good expression and homogenous distribution of CFP. Cells were fixed using 4% formaldehyde and addition of VECTASHIELD. Imaging was performed with a confocal microscope, the white bar has a length of 50μm objective. </td> | + | <td>U-2 OS cells transiently transfected with <a href="http://partsregistry.org/wiki/index.php?title=Part:BBa_K678053">pJEJAM5</a> expressing CFP. This vector provides a good expression and homogenous distribution of CFP. The white bar has a length of 50μm. </td> |
| | </tr> | | </tr> |
| | </table> | | </table> |
| | | | |
| - | <br> | + | <br><br> |
| - | <br> | + | <a name="Play'n'Mix"></a><h2>Mix'n'Play </h2> |
| - | <br>
| + | |
| - | <br>
| + | |
| - | | + | |
| - | <a name="Play'n'Mix"></a><h2>Play'n'Mix</h2> | + | |
| | | | |
| | Mammalian cells can be transiently transfected with several plasmids at once, allowing the simultaneous expression of different fluorescent proteins. The pictures below demonstrate different combinations of fluorescent proteins. | | Mammalian cells can be transiently transfected with several plasmids at once, allowing the simultaneous expression of different fluorescent proteins. The pictures below demonstrate different combinations of fluorescent proteins. |
| Line 258: |
Line 232: |
| | | | |
| | <tr> | | <tr> |
| - | <td ><center><img src="https://static.igem.org/mediawiki/2011/ c/ c5/ 26.08.2011_12-1% 2B16_033. tif" height="250px" align="center"> </img ></center></td> | + | <td><img src="https://static.igem.org/mediawiki/2011/7/78/Grøn_%2Bblå.png" height="250px" align="center"> </img></td> |
| - | <td ><center><img src="https://static.igem.org/mediawiki/2011/ c/ c5/ 26.08.2011_12-1% 2B16_033. tif" height="250px" align="center"> </img ></center></td> | + | <td><img src="https://static.igem.org/mediawiki/2011/9/99/16_blå%2Bgrøn.png" height="250px" align="center"> </img></td> |
| | + | |
| | </tr> | | </tr> |
| | | | |
| | <tr> | | <tr> |
| - | <td>U-2 OS cells transiently transfected with plasmid pJEJAM2 expressing GFP localized to the peroxisomes. As can be seen on the picture this vector as intended localizes GFP to the peroxisomes of the cells. Cells were fixed using 4% formaldehyde and addition of VECTASHIELD. Imaging was performed with a confocal microscope, the white bar has a length of 30μm objective. </td> | + | <td>U-2 OS cells transiently transfected with <a href="http://partsregistry.org/wiki/index.php?title=Part:BBa_K678050">pJEJAM2</a> and <a href="http://partsregistry.org/wiki/index.php?title=Part:BBa_K678053">pJEJAM5</a> expressing GFP localized to the peroxisomes and CFP, respectively. The white bar has a length of 30μm. </td> |
| | + | <td>U-2 OS cells transiently transfected with <a href="http://partsregistry.org/wiki/index.php?title=Part:BBa_K678049">pJEJAM1</a> and <a href="http://partsregistry.org/wiki/index.php?title=Part:BBa_K678053">pJEJAM5</a> expressing GFP and CFP, respectively. The white bar has a length of 30μm. </td> |
| | </tr> | | </tr> |
| - | </table>
| |
| - | <br>
| |
| - | <br>
| |
| - | <br>
| |
| - | <br>
| |
| | | | |
| - | <a name="References"></a><h2><References</h2> | + | <tr> |
| - | <p align="justify"> | + | <td><img src="https://static.igem.org/mediawiki/2011/1/10/1%2B15_033.png" height="250px" align="center"> </img></td> |
| - | (1) Hesse, F., Wagner, R. (2000). Developments and improvements in the manufacturing of human therapeutics with mammalian cell cultures. TIBTECH, 18, 173-180.<br><br>
| + | <td><img src="https://static.igem.org/mediawiki/2011/6/6b/14%2B16_033.png" height="250px" align="center"> </img></td> |
| | + | </tr> |
| | | | |
| - | (2) Global Biopharmaceutical Market Report (2010-2015). (2010). The International Market Analysis Research and Consulting Group.<br><br>
| + | <tr> |
| | + | <td>U-2 OS cells transiently transfected with <a href="http://partsregistry.org/wiki/index.php?title=Part:BBa_K678049">pJEJAM1</a> and <a href="http://partsregistry.org/wiki/index.php?title=Part:BBa_K678052">pJEJAM4</a> expressing GFP and mCherry, respectively. The white bar has a length of 70μm. </td> |
| | + | <td>U-2 OS cells transiently transfected with <a href="http://partsregistry.org/wiki/index.php?title=Part:BBa_K678052">pJEJAM3</a> and <a href="http://partsregistry.org/wiki/index.php?title=Part:BBa_K678053">pJEJAM5</a> expressing YFP and CFP, respectively. The white bar has a length of 40μm. </td> |
| | + | </tr> |
| | | | |
| - | (3) Xie, L., Zhou, W., Robinson, D. (2003). Protein production by large-scale mammalian cell culture. S.C. Makrides (Ed.) Gene Transfer and Expression in Mammalian Cells. Elsevier Science B.V.<br><br>
| + | </table> |
| - | | + | |
| - | (4) Browne, SM., Al-Rubeai, M. (2007). Selection methods for high-producing mammalian cell lines. TRENDS in Biotechnology, 25, 425-432.<br><br>
| + | |
| - | | + | |
| - | (5) Walsh, W., Jefferis, R. (2006). Post-translational modifications in the context of therapeutic proteins. Nature Biotechnology, 24, 1241-1252.<br><br>
| + | |
| - | </p> | + | |
| | <br> | | <br> |
| | <br> | | <br> |
| - |
| |
| - |
| |
| - |
| |
| | | | |
| | | | |
| Line 297: |
Line 264: |
| | </tr> | | </tr> |
| | </table> | | </table> |
| | + | </div> |
| | <div id="EndOfPage"></div> | | <div id="EndOfPage"></div> |
| | <script type="text/javascript" src="http://ajax.googleapis.com/ajax/libs/jquery/1.4.2/jquery.min.js" charset="utf-8"></script> | | <script type="text/javascript" src="http://ajax.googleapis.com/ajax/libs/jquery/1.4.2/jquery.min.js" charset="utf-8"></script> |
"
